-
Surgical wounds close more frequently and faster, infections are rarer than with standard care. However, 23% of the data from completed studies are still not available.
-
External measurements taken on the scalp allow conclusions to be drawn about the underlying nerve cell activity.
-
Researchers at John Hopkins University have identified a pair of proteins that control when hair cells form in mammalian ears, to great precision. The research team believes these proteins may help restore hearing in people with irreversible deafness.
-
New SLE classification criteria intend to help patients with SLE to be recognized more quickly and to be treated more effectively.
-
Tattoos could become interesting from a diagnostic point of view. Scientists have succeeded for the first time in developing tattoos that work like disease-indicating sensors.
-
Timely lifestyle changes can protect people at high risk of age-related macular degeneration (AMD) from vision loss into old age. This is a key intermediate result of the European research project EYE-RISK.
-
Dr. Philipp Kellmeyer, a researcher at the Freiburg University Hospital (Germany), calls for more sensitive use of virtual realities in medicine and nursing.
-
Overactive nerve cells in certain areas of the brain are considered an early symptom of Alzheimer's disease. For the first time, a team from the Munich Technical University (TUM) was able to elucidate the causes and mechanisms of this initial and important step.
-
Severe and persistent pancreatic pain is difficult to treat because many painkillers do not work in this organ. In a recent study, a team has discovered the reason: A certain endogenous nerve messenger substance is present in the pancreas’ nerves in very high concentrations.
-
Researchers found that in people with celiac disease, following gluten ingestion, certain inflammatory molecules associated with clinical symptoms occur in the bloodstream. These recently discovered biomarkers are the basis for the blood test.
-
Therapy with the PARP inhibitor olaparib prolonged progression-free survival in severely pretreated patients with metastatic castration-resistant prostate cancer and defective DNA repair mechanisms by approximately 4 months compared to hormone therapy with enzalutamide or abiraterone.
-
Food allergies can be caused by the absence of certain intestinal bacteria. Current study results show that the replacement of these intestinal bacteria could make a decisive contribution to the treatment of allergies.
-
The PD-L1 inhibitor atezolizumab, when added to chemotherapy, prolonged the progression-free survival of untreated patients with metastatic bladder cancer from 6.3 to 8.2 months compared to chemotherapy.
-
Additional treatment with abemaciclib or ribociclib may prolong survival in women with advanced hormone receptor-positive and HER-2-negative breast cancer.
-
Tumors with mismatch repair deficiency (MMRD) or tumors with high tumor mutational burden (TMB) respond better to therapy with checkpoint inhibitors than tumors without these properties.
-
New data for prognostic markers in early breast cancer as well as further analyses of the Phase 3 studies TAILORx and KATHERINE were presented at the ESMO Congress 2019 in Barcelona.
-
Could smartphones be used to measure blood pressure? Canadian and Chinese researchers are suggesting that the smartphone camera could be used to make it easier to check blood pressure.
-
A vast array of study results on melanoma were presented by Piotr Rutkowski, from the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland, during a highlight session at the ESMO Congress 2019.
-
Sarcomas are relatively rare tumors that can occur on the soft tissue or bone. New study data on their treatment was presented by Javier Martin-Broto, Virgen del Rocio University Hospital, Seville, Spain.
-
Treatment with a combined immunotherapy of nivolumab plus low-dose ipilimumab prolonged overall survival compared to chemotherapy in previously untreated patients with advanced NSCLC regardless of PD-L1 expression of the tumor.
